09966.HK
Alphamab Oncology
HKSE · Healthcare · Biotechnology · CN
HKD 8.77
−1.02%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 67.09x
Trailing multiples
Trailing twelve months
- P/E TTM
- 110.38x
- PEG TTM
- —
- Price / book
- 4.32x
- Price / sales
- 5.56x
- Price / cash flow
- -59.26x
Enterprise value
- Enterprise value
- HKD 7.1B
- EV / sales
- 4.66x
- EV / EBITDA
- 53.85x
- EV / EBIT
- -791.32x
- Market cap
- HKD 8.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026